Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal administration for postoperative sleep and anxiety after plastic surgery under general anesthesia
ChiCTR1900020822Phase 4Recruiting
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in sleep disorder and anxiety disorder (2 arms), sponsored by Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started Dec 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorderanxiety disorder
Beyond the preview
Go deeper on ChiCTR1900020822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020822.